A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...
First-in-class immune-stimulating antibody conjugate BDC-4182 in Phase 1 dose escalation study, initial clinical data expected in 3Q 2026 Cash ...
Taking aim at the leading risk factor for cancer, The Mark Foundation for Cancer Research and the Samuel Waxman Cancer Research Foundation (SWCRF) today announced $2.5 million to support science at ...
KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for KOMODO-1 ...
To improve the treatment of patients with metastatic cancer, responsible for 67%-90% of all cancer-related deaths, there is an “urgent” need to abandon the classification of tumors by organ of origin, ...
Iovance Biotherapeutics' most important product has strong momentum right now. However, the company faces significant challenges that make the stock risky. Iovance could soar if it can overcome the ...
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients ...
York, Pa., Feb. 23, 2026 (GLOBE NEWSWIRE) -- WellSpan Health and Cancer Care Associates of York (CCAY) today announced a strategic partnership that will advance world-class cancer care for patients ...
Ripple effect: Microsoft's latest Windows experiment hints at a shift in how GenAI will surface across the operating system. Instead of relying on standalone new apps or flashy new interfaces, plans ...
ImmunityBio received conditional marketing authorization from the European Commission for its Anktiva immunotherapy, to be used in conjunction with the Bacillus Calmette-Guérin (BCG) vaccine, when ...
SLAMF6 is an immune cell receptor whose function was not clear. Does it activate or inhibit cells? The results so far have been contradictory. Now, scientists at the Institut de Recherches Cliniques ...
David Boreanaz (R) reached out to James Garner's daughter about his casting in the 'Rockford Files' reboot. TV Guide/Courtesy Everett Collection/Gilbert Flores/PMC As David Boreanaz prepares to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results